229 related articles for article (PubMed ID: 32210548)
1. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk.
Langholm LL; Rønnow SR; Sand JMB; Leeming DJ; Tal-Singer R; Miller BE; Vestbo J; Karsdal MA; Manon-Jensen T
Int J Chron Obstruct Pulmon Dis; 2020; 15():543-552. PubMed ID: 32210548
[TBL] [Abstract][Full Text] [Related]
2. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.
Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ; Sand JMB
Respir Res; 2020 Jul; 21(1):202. PubMed ID: 32731895
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
4. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
[TBL] [Abstract][Full Text] [Related]
5. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
[TBL] [Abstract][Full Text] [Related]
6. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
[TBL] [Abstract][Full Text] [Related]
7. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients.
Polosa R; Malerba M; Cacciola RR; Morjaria JB; Maugeri C; Prosperini G; Gullo R; Spicuzza L; Radaeli A; Di Maria GU
Intern Emerg Med; 2013 Oct; 8(7):567-74. PubMed ID: 21660493
[TBL] [Abstract][Full Text] [Related]
9. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation.
Hao W; Li M; Zhang C; Zhang Y; Xue Y
Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361
[TBL] [Abstract][Full Text] [Related]
10. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
11. End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
Manon-Jensen T; Langholm LL; Rønnow SR; Karsdal MA; Tal-Singer R; Vestbo J; Leeming DJ; Miller BE; Bülow Sand JM
Respir Med; 2019; 160():105814. PubMed ID: 31739246
[TBL] [Abstract][Full Text] [Related]
12. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of von Willebrand factor in COPD patients.
Bártholo TP; Costa CH; Rufino R
J Bras Pneumol; 2014; 40(4):373-9. PubMed ID: 25210959
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
[TBL] [Abstract][Full Text] [Related]
15. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
[TBL] [Abstract][Full Text] [Related]
16. Blood eosinophil count as a prognostic biomarker in COPD.
Oh YM; Lee KS; Hong Y; Hwang SC; Kim JY; Kim DK; Yoo KH; Lee JH; Kim TH; Lim SY; Rhee CK; Yoon HK; Lee SY; Park YB; Jung JH; Kim WJ; Lee SD; Park JH
Int J Chron Obstruct Pulmon Dis; 2018; 13():3589-3596. PubMed ID: 30464441
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
18. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
20. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure.
Claus RA; Bockmeyer CL; Budde U; Kentouche K; Sossdorf M; Hilberg T; Schneppenheim R; Reinhart K; Bauer M; Brunkhorst FM; Lösche W
Thromb Haemost; 2009 Feb; 101(2):239-47. PubMed ID: 19190805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
